Bladder papillary urothelial carcinoma

MONDO:0004056

An invasive or non-invasive papillary transitional cell carcinoma of the urinary bladder. It is classified as low - or high-grade. -- 2003

Also known as: bladder papillary urothelial carcinoma, urinary bladder papillary transitional cell carcinoma, urothelial papillary carcinoma of the bladder, bladder urothelial papillary carcinoma

2780 clinical trials for this condition and its sub-types, 11 tagged with Bladder papillary urothelial carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Bladder transitional cell carcinoma (411) ↑ Bladder papillary urothelial neoplasm (13) ↑ Papillary transitional cell carcinoma (11)

Including sub-types (2780) Tagged with Bladder papillary urothelial carcinoma (11)

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 2

New bladder cancer drug could spare patients from bladder removal

Disease control Not yet recruiting

This Phase 3 trial tests NDV-01, a sustained-release combination of two chemotherapy drugs (gemcitabine and docetaxel), given directly into the bladder. It aims to prevent cancer from coming back in people with non-muscle invasive bladder cancer, including those who have not resp…

Phase 3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC

Bladder papillary urothelial carcinoma

Where it sits in the disease tree

New bladder cancer drug could spare patients from bladder removal